| scholarly article | Q13442814 |
| P50 | author | Amalia Gastaldelli | Q43294287 |
| P2093 | author name string | Eugenio Cersosimo | |
| Kenneth Cusi | |||
| Mandeep Bajaj | |||
| Sangeeta Kashyap | |||
| P2860 | cites work | Molecular identification of nicotinic acid receptor | Q28184800 |
| Molecular identification of high and low affinity receptors for nicotinic acid | Q28202556 | ||
| Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome | Q31811259 | ||
| The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects | Q33836122 | ||
| The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus | Q33853759 | ||
| Fuel selection in human skeletal muscle in insulin resistance: a reexamination | Q33975119 | ||
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial | Q33999757 | ||
| Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes | Q34424907 | ||
| A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis | Q34585893 | ||
| Relationship between insulin-mediated glucose disposal and lipid metabolism in man. | Q34624238 | ||
| The nicotinic acid receptor--a new mechanism for an old drug | Q35796319 | ||
| Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus | Q35989381 | ||
| Effect of fatty acids on glucose production and utilization in man | Q36992461 | ||
| Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation | Q37378805 | ||
| Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle | Q40334538 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. | Q41275648 | ||
| A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes | Q42450726 | ||
| Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects | Q42453208 | ||
| Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans | Q42461702 | ||
| Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes | Q42467298 | ||
| Glucose-induced insulin hypersecretion in lipid-infused healthy subjects is associated with a decrease in plasma norepinephrine concentration and urinary excretion | Q43766475 | ||
| Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 | ||
| Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians | Q43850960 | ||
| Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. | Q44043219 | ||
| Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects | Q44251616 | ||
| Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content | Q44473913 | ||
| Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance | Q44831737 | ||
| The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo | Q44953988 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia | Q46498930 | ||
| Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. | Q51567209 | ||
| Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders. | Q51579221 | ||
| Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. | Q51584824 | ||
| The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents | Q51603248 | ||
| Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. | Q53617326 | ||
| Obesity and insulin resistance in humans: a dose-response study. | Q54325234 | ||
| Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. | Q54346849 | ||
| P433 | issue | 6 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | E1775-81 | |
| P577 | publication date | 2007-02-13 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. | |
| P478 | volume | 292 |
| Q28074377 | A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease. |
| Q34392359 | Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults |
| Q36975760 | American College of Endocrinology Pre-Diabetes Consensus Conference: part three |
| Q47139281 | Berberis integerrima ameliorates insulin resistance in high- fructose-fed insulin-resistant rats |
| Q91926297 | Breakfast consumption modulates postprandial glycaemic, insulinaemic and NEFA response in pre-diabetic Asian males |
| Q47907933 | Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet-induced obesity rats |
| Q35055437 | Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue |
| Q35578244 | Dapagliflozin lowers plasma glucose concentration and improves β-cell function |
| Q37268274 | Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus |
| Q26824349 | Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease |
| Q36716030 | Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males |
| Q88585228 | Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes |
| Q33759055 | Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes |
| Q35432791 | Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug |
| Q58200110 | Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients |
| Q35597914 | Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids |
| Q35440499 | Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters |
| Q34171831 | Future of GPR109A agonists in the treatment of dyslipidaemia |
| Q44066995 | GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus. |
| Q37921903 | Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? |
| Q33665283 | Glucolipotoxicity of the pancreatic beta cell. |
| Q37269512 | Glucolipotoxicity of the pancreatic beta-cell: myth or reality? |
| Q36861036 | Glucolipotoxicity: fuel excess and beta-cell dysfunction. |
| Q46068667 | Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. |
| Q43294210 | Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis |
| Q42756047 | Insulin concerns and promises |
| Q37505520 | Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus |
| Q38222135 | Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. |
| Q36610458 | Lipotoxicity: effects of dietary saturated and transfatty acids |
| Q26822794 | Metabolomics in diabetes research |
| Q64245267 | NAD metabolism as a target for metabolic health: have we found the silver bullet? |
| Q37376937 | Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia |
| Q37001269 | Obesity and free fatty acids |
| Q35204838 | Obesity, insulin resistance and free fatty acids |
| Q44906014 | Overexpression of glutathione peroxidase 4 prevents β-cell dysfunction induced by prolonged elevation of lipids in vivo |
| Q34072312 | Oxidative stress, nitric oxide, and diabetes |
| Q37194756 | Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus. |
| Q37575114 | Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. |
| Q51541168 | Potentiation of the early-phase insulin response by a prior meal contributes to the second-meal phenomenon in type 2 diabetes. |
| Q35841222 | Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). |
| Q49984998 | Prior ingestion of exogenous ketone monoester attenuates the glycemic response to an oral glucose tolerance test in healthy young individuals. |
| Q24617779 | Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men |
| Q37921905 | Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus |
| Q34615491 | Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans |
| Q34526790 | The Effects of Breakfast Consumption and Composition on Metabolic Wellness with a Focus on Carbohydrate Metabolism |
| Q51378468 | The effect of a supported exercise programme in patients with newly diagnosed Type 2 diabetes: a pilot study. |
| Q43276340 | The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and obese nondiabetic men. |
| Q37765850 | The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes |
| Q46610477 | Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. |
| Q51047392 | Very-long-chain ω-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial |
| Q33610688 | Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue |
Search more.